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In Brief
James et al. show that the non-enzymatic
N-acetylation of lysine residues in
mitochondrial proteins frequently occurs
via a proximal S-acetylated thiol
intermediate. Glutathione equilibrates
with this intermediate, allowing the
thioesterase glyoxalase II to limit protein
lysine N-acetylation. These findings
expand our understanding of how protein
acetylation arises.
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Acetyl coenzyme A (AcCoA), a key intermediate in
mitochondrial metabolism, N-acetylates lysine resi-
dues, disrupting and, in some cases, regulating pro-
tein function. The mitochondrial lysine deacetylase
Sirtuin 3 (Sirt3) reverses this modification with bene-
fits reported in diabetes, obesity, and aging. We
show that non-enzymatic lysine N-acetylation by
AcCoA is greatly enhanced by initial acetylation of a
cysteine residue, followed by SN-transfer of the
acetyl moiety to a nearby lysine on mitochondrial
proteins and synthetic peptides. The frequent occur-
rence of an S-acetyl intermediate before lysine
N-acetylation suggests that proximity to a thioester
is a key determinant of lysine susceptibility to acety-
lation. The thioesterase glyoxalase II (Glo2) can limit
protein S-acetylation, thereby preventing subse-
quent lysine N-acetylation. This suggests that the
hitherto obscure role of Glo2 in mitochondria is to
act upstreamof Sirt3 inminimizing proteinN-acetyla-
tion, thus limiting protein dysfunction when AcCoA
accumulates.
INTRODUCTION
Acetyl coenzyme A (AcCoA) is central to mitochondrial meta-
bolism, providing acetyl groups to the citric acid cycle from the
oxidation of carbohydrate and fat (Pietrocola et al., 2015). One
way that AcCoA affects mitochondria is through N-acetylation
of the ε-amino of lysine residues on mitochondrial proteins.
The significance of N-acetylation is implied by the existence of
a mitochondrial deacetylase, sirtuin 3 (Sirt3), which uses NAD+
to remove acetyl groups from lysine residues, and by the obser-
vation that Sirt3 is important in the pathology of a range of
degenerative diseases, including cancer, aging, and diabetes
(McDonnell et al., 2015).Cell Re
This is an open access article undAlthough the enzymatic basis of the deacetylation of
N-acetylated lysine residues by Sirt3 is established, the mech-
anism by which mitochondrial AcCoA acetylates lysine residues
is less certain. Although a mitochondrial N-acetyltransferase
(Gcn5L1) has been proposed (Scott et al., 2012), more inter-
esting in the context of degenerative disease is the observation
that mitochondrial protein is non-enzymatically N-acetylated on
lysine residues by AcCoA (Wagner and Payne, 2013; Wagner
and Hirschey, 2014; Weinert et al., 2015; Davies et al., 2016).
The mitochondrial concentration of coenzyme A (CoA) in vivo
(1 mM) is usually higher than AcCoA (100–500 mM) (Garland
et al., 1965), but this shifts in the presence of fatty acids with
AcCoA rising (1 mM) and CoA falling (100–300 mM). Conse-
quently, both the mitochondrial concentration of AcCoA and
the AcCoA/CoA ratio alter markedly upon changes to nutrition
or exercise. Whether protein lysine acetylation is a damaging
consequence of relying on AcCoA for metabolism or a regula-
tory pathway to respond to changes in AcCoA, the AcCoA/CoA
ratio or NAD+ is unclear. Even so, Sirt3 plays a major patho-
physiological role in reversing the damaging lysine N-acetyla-
tion of mitochondrial proteins that arises from exposure to
excess AcCoA.
The mechanism proposed for non-enzymatic lysine acetyla-
tion was a nucleophilic attack by the side-chain amine on the
acetyl carbonyl (Wagner and Payne, 2013). This direct reaction
will be slow in the mitochondrial matrix (pH 7.8), because the
pKa of a free lysine is 10.5. Although this rate can be enhanced
by stabilization of the amine, protein cysteine residues are on
average better nucleophiles (pKa 8.5) (Thapa et al., 2014).
Because cysteine-containing peptides can be directly S-acety-
lated by AcCoA in vitro (Bizzozero et al., 2001), we postulated
that S-acetylation of protein cysteine thiols would be far
higher than N-acetylation of lysine amines. Here we show that
S-acetylation is a frequent modification and that non-enzymatic
N-acetylation of lysine residues by AcCoA occurs predominantly
via a proximal S-acetylated thiol intermediate. We also show
that glutathione (GSH) and glyoxalase II (Glo2), also known as
hydroxyacyl glutathione hydrolase (HAGH), together can limit
S-acetylation and consequently N-acetylation.ports 18, 2105–2112, February 28, 2017 ª 2017 The Authors. 2105
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. AcCoA Non-enzymatically Acety-
lates Mitochondrial Protein
(A) Structure of AcCoA.
(B and C) Lysine acetylation by AcCoA is con-
centration dependent, has a high apparent KM,
and resembles in vivo acetylation. (B) Mitochon-
drial membranes were incubated with AcCoA at
37C for 6 hr, followed by reducing SDS-PAGE.
The green channel without AcCoA was over-
exposed for comparison. (C) After SDS-PAGE,
acetyllysine (green) and NDUFB8 (red) were visu-
alized (n = 2 ± range). (D) Total acetylation is
temperature sensitive. Mitochondrial membranes
were incubated with 2 mM 14C-AcCoA on ice or at
37C.
(E) Total acetylation is concentration dependent.
Mitochondrial membranes were incubated with
50 mM 14C-AcCoA and 0–2 mM AcCoA at
37C. The reaction contained sufficient CoA to
keep AcCoA+CoA at 2 mM. Bound acetyl was
calculated using the combined specific activity of
14C-AcCoA and AcCoA.
(F) Acetylation is influenced by CoA. Incubations
as for (E) but recalculated as 14C-acetyl bound
(dpm) irrespective of specific activity. This was
normalized to 2 mM AcCoA (N).
All data are the mean ± SEM of at least three
experiments unless otherwise stated. See also
Figure S1.RESULTS
Mitochondrial Proteins Are Acetylated by AcCoA
It has been shown using an anti-acetyllysine antibody that
mitochondrial proteins can be non-enzymatically N-acetylated
on lysine residues by AcCoA (Wagner and Payne, 2013). To
explore this further, we incubated bovine heart mitochondrial
membrane fragments that lack metabolites or matrix proteins
with AcCoA. Lysine acetylation was concentration dependent
(Figure 1B) in the physiological range for AcCoA with an
apparent KM of 5.4 mM (Figure 1C). The anti-acetyllysine anti-
body recognizes acetyllysine modifications (Figures S1A and
S1B), and the pattern of lysine acetylation observed in this
in vitro system resembles that of in vivo lysine acetylation
(Figure 1B).
The mechanism proposed for lysineN-acetylation is via nucle-
ophilic attack on AcCoA by the side-chain amine of a lysine res-
idue (Wagner and Payne, 2013). However, the pKa of a lysine
amine is10.5,making themore nucleophilicNH2 form aminor
species in vivo without stabilization. In contrast, cysteine resi-2106 Cell Reports 18, 2105–2112, February 28, 2017dues are better nucleophiles at physiolog-
ical pH, with significant amounts of the
thiolate available for reaction (pKa 8.5).
Consequently, a major proportion of pro-
tein acetylation may be invisible to the
anti-acetyllysine antibodies commonly
used. To investigate total acetylation of
mitochondrial protein by AcCoA, we incu-
bated mitochondrial membranes with
14C-AcCoA. As expected, membrane-associated 14C increased with time and temperature (Figure 1D),
consistent with a reaction between AcCoA and protein. The
in vivo concentration of AcCoA plus CoA is likely to be stable
1–2 mM (Garland et al., 1965). To reflect this, we incubated
mitochondrialmembraneswith 50mM14C-AcCoA supplemented
with varying ratios of AcCoA and CoA to a total concentration of
2mMAcCoA+CoA. The rate of protein acetylation was a function
of the AcCoA concentration (Figure 1E) and the AcCoA/CoA
ratio (Figure 1F) in the physiological range for AcCoA.
Thus, acetylation of mitochondrial proteins occurs in vitro in
a time-, temperature-, and concentration-dependent manner
without matrix proteins, other water-soluble metabolites, or co-
factors. It has a high apparent KM, and the pattern of proteins
modified resembles in vivo acetylation.
Mitochondrial Proteins Are S-acetylated by AcCoA
To test whether AcCoA modified cysteine residues we included
the thiol-alkylating reagent, N-ethyl maleimide (NEM; 25 mM).
NEM reacts irreversibly with thiols and should block the transfer
of the acetyl group of AcCoA to cysteines. Although NEM is
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Figure 2. AcCoA Acetylates Lysine Resi-
dues via a Proximal Acetylcysteine
Intermediate
(A) Total acetylation is sensitive to thiol-blocking
reagents. Mitochondrial membranes were incu-
bated with 2 mM 14C-AcCoA and 25 mM NEM,
IAM, or MMTS at 37C for up to 6 hr.
(B) Alkylating reagents do not break down AcCoA.
Mitochondrial membranes were incubated with
2 mM AcCoA and 25 mM NEM, IAM, or MMTS at
37C for up to 6 hr. AcCoA was measured by liquid
chromatography-tandem mass spectrometry (LC-
MS/MS) (n = 2 ± range).
(C) Total acetylation is sensitive to thioester-
cleaving reagents. Mitochondrial membranes were
incubated with 2 mM 14C-AcCoA at 37C for 3 hr.
Afterward, 20mMDTT, HA, or TCEPwas added for
30 min at 37C.
(D and E) N-acetylation is sensitive to thiol-block-
ing reagents. (D) Mitochondrial membranes were
incubated with 2 mM AcCoA and 25 mM NEM,
IAM, or MMTS at 37C for 6 hr. For others, 20 mM
DTT was added for 30 min after the reaction.
After reducing SDS-PAGE, acetyllysine (green) and
NDUFB8 (red) were visualized. (E) The extent of
lysine acetylation was quantified (n = 3 ± SD).
(F–H) Proximal thiol facilitates lysine acetylation as
is shown in (F). A cysteine-containing peptide
(CysPep; 200 mM) and a serine-containing peptide
(SerPep; 200 mM) were coincubated with 200 mM
AcCoA. To differentiate S-acetylcysteine from
N-acetyllysine and O-acetylserine, 20 mM DTT
was added for 30 min after the reaction. A mix of
deuterated (d7) standards was then added to
quantify acetylation (Ac-SerPep and Ac-CysPep)
by MALDI-TOF. The spectrum in (G) is after 3 hr
with DTT added. (H) The extent of acetylation was
quantified (n = 3 ± SD).
All data are the mean ± SEM of at least three ex-
periments unless otherwise stated. NS, not signif-
icant; *p < 0.05; **p < 0.01; ****p < 0.0001. See also
Figures S1 and S2.selective for thiols, over long periods at pH 8, it also alkylates
amines (Figures S1C and S1D) and can disrupt secondary struc-
ture (Figure S2A). Thus, we used two further thiol-blocking re-
agents, iodoacetamide (IAM; 25 mM) and methylmethanethio-
sulfonate (MMTS; 25 mM) that react more selectively with
cysteine residues (Figures S1E and S1F). After 3 hr, 85%,
79%, and 83% of acetylation was prevented by NEM, IAM,
and MMTS, respectively, suggesting substantial acetylation of
cysteines by 14C-AcCoA (Figure 2A). To ensure NEM, IAM, and
MMTS were not degrading AcCoA, we measured the change
in AcCoA concentration by electrospray ionization (ESI) mass
spectrometry (MS) (Figure 2B). After 3 hr, 70% of the AcCoA re-
mained, and NEM, IAM, and MMTS did not accelerate AcCoACell Repodegradation. Thus, the lack of acetylation
with NEM, IAM, andMMTS is not because
exposure to AcCoA is diminished.
Consistent with acetylation of cysteine
thiols, 71% of bound 14C could beremoved by excess DTT (20 mM for 30 min), a broad specificity
thiol reductant, after incubation with 14C-AcCoA (Figure 2C).
Acetylation was reversed to a similar degree (67%) by hydroxyl-
amine (HA; 50 mM for 30 min), a nucleophile with specificity for
thioesters (Figure S2B), after the incubation with 14C-AcCoA
(Figure 2C). Acetylation was insensitive to tris(2-carboxyethyl)
phosphine (TCEP) (Figure 2C), a disulfide-reducing agent un-
reactive with thioesters (Figure S2B).
Acetyl Moieties Migrate from Cysteine to Lysine
Residues
Removing acetyl groups with DTT post-incubation was less
effective at decreasing protein acetylation than blocking proteinrts 18, 2105–2112, February 28, 2017 2107
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Figure 3. GSH and Glo2 Limit Acetylation
(A) Acetylation is insensitive to the presence of GSH. Mitochondrial membranes were incubated with 2 mM 14C-AcCoA with or without 10 mM GSH at 37C for
3 hr. At that point, an excess of DTT or GSH was added to some incubations for 30 min at 37C.
(B) GSH breaks down AcCoA. AcCoA (2 mM) was incubated with or without 10 mM GSH and with or without mitochondrial membranes at 37C for up to 6 hr.
AcCoA was measured by LC-MS/MS. Data are the mean ± range of two experiments.
(C) S-acetylglutathione and AcCoA N-acetylate lysine residues are shown, and this is prevented by Glo2. Mitochondrial membranes were incubated with 2 mM
AcCoA or 2 mM S-acetylglutathione at 37C for 6 hr. This was supplemented with GSH (10 mM), NAD+ (1 mM), NADPH (1 mM), Glo2 (1 mg/mL), GR (0.1 mg/mL),
Grx2 (1 mg/mL), or Sirt3 (10 mg/mL) during the 6 hr incubation. Excess GSHwas then added for 30min as indicated. After reducing SDS-PAGE, acetyllysine (green)
and NDUFB8 (red) were visualized.
(D) Acetylation by AcCoA is limited by Glo2 and Sirt3. Mitochondrial membranes were incubated with 2 mM 14C-AcCoA at 37C for 6 hr. GSH (10 mM), Glo2
(1 mg/mL), NAD+ (1 mM), and Sirt3 (10 mg/mL) were added as indicated.
(legend continued on next page)
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thiols with NEM, IAM, or MMTS preincubation, and the relative
ineffectiveness of DTT increased with time (Figure S2C). Intra-
molecular SN-transfer reactions are often favorable and are
used by enzymes such as acetyltransferases (Yan et al., 2002),
as well as during native chemical ligation of peptides (Thapa
et al., 2014). An increasing difference with time between preincu-
bation with NEM, IAM, and MMTS and post-incubation with DTT
(Figure S2C) could arise if AcCoA first S-acetylates a cysteine
thiol through reversible thioester exchange and the acetyl moiety
subsequently migrates in an irreversible intramolecular SN-
transfer reaction to a nearby lysine. Consistent with this, preincu-
bation of membranes with NEM, IAM, and MMTS all decreased
lysineN-acetylation by western blot (Figures 2D, 2E, and S2D). In
contrast to 14C-AcCoA (Figure 2C), post-incubation with DTT
failed to remove the N-acetylation signal resulting from AcCoA.
To show this intramolecular SN-transfer reaction is a general
proximity-based process that can occur on amino acid side
chains without a favorable secondary structure that might bind
AcCoA or stabilize nucleophiles, two peptides were synthesized
that contained either a cysteine (CysPep) or a serine (SerPep)
near a lysine residue (Figure 2F). Four deuterated standards
were also made to facilitate quantification by MS (Figures
S2E). When 200 mM of both peptides were simultaneously coin-
cubated with 200 mM AcCoA in a competition assay, DTT-sensi-
tive acetylation of CysPep rapidly increased, peaking at 20 min
(Figure 2H). The initial rate of total acetylation of CysPep was
300-fold greater than that of SerPep, confirming the favorability
of S-acetylation relative to direct N-acetylation. DTT-insensitive
acetylation of CysPep (m/z = 1,122) continued to increase
and was 23-fold higher (n = 3, p < 0.0001) than that of SerPep
(m/z = 1,106) after 1 hr. At 3 hr, an additional DTT-insensitive
peak (m/z = 1,164) appeared, consistent with CysPep acetylated
on both lysine and serine (Figure 2G), and these modifications
were confirmed by MALDI-TOF-TOF MS. Thus, initial reversible
S-acetylation of a cysteine thiol via rapid thioester equilibration
can facilitate subsequent SN-transfer of the acetyl moiety to a
nearby lysine or serine residue. The rate of serine residue
acetylation (pKa 13) is expected to be slower than for lysine.
GSH Alone Does Not Prevent S-acetylation
High concentrations of the free thiol GSH could limit acetylation
of protein thiols in vivo. Thus, we tested whether protein thiols
could be acetylated in the presence of physiological concentra-
tions of GSH (10 mM) and AcCoA (2 mM) and a physiological
GSH-to-AcCoA ratio of 5 (Figure 2C). Surprisingly, 10 mM
GSH during the 3 hr incubation with AcCoA only prevented 5%
of the acetylation (Figure 3A). In contrast, an unphysiological
2,000-fold excess of GSH to protein thiols, added after the reac-
tion of protein with AcCoA, removed 53% of the protein-bound
acetyl moieties (Figure 3A), a level approaching DTT and HA (Fig-
ure 2C). Thus, S-acetylation of cysteine thiols still occurs with
physiological concentrations of AcCoA andGSHbut is reversible
with excess GSH.(E and F)N-succinylation by succinylCoA (SuccCoA) is limited by Glo2, but not Sir
37C for 6 hr. This was supplemented with GSH (10 mM), NAD+ (1 mM), Glo2 (1 mg
PAGE, succinyllysine (green) and NDUFB8 (red) were visualized. (F) The extent o
All data are the mean ± SEM of at least three experiments unless otherwise stateGlo2 and GSH Limit Mitochondrial Protein Acetylation
Despite suggesting limited direct interaction between GSH and
AcCoA, GSH caused a rapid decline in AcCoA (Figure 3B) and
the appearance of a mass consistent with acetylglutathione
(m/z = 348). This reaction did not require the presence of protein
(Figure 3B) and is consistent with thioester equilibration between
AcCoA and GSH. One explanation for why GSH did not prevent
protein acetylation, despite depleting AcCoA, is thatS-acetylglu-
tathione (AcGS) also acetylates proteins. Incubation of mito-
chondrial membranes with 2 mM S-acetylglutathione (Figure 3C)
led to N-acetylation of lysine residues increasing 44-fold.
Although the pattern of protein acetylation was similar to that
caused by AcCoA alone, the extent of lysine modification was
3.1 ± 0.2-fold higher. Acetylation by S-acetylglutathione was
also sensitive to NEM, IAM, and MMTS (Figure S3A). There
was no acetylation by O-linked acetylcarnitine (Figure S3B).
S-acetylglutathione is a good substrate for Glo2, an enzyme
that hydrolyses a range of thioesters conjugated to GSH (Talesa
et al., 1989). Glo2 catalyzes the second stage of the two-step
detoxification pathway for glyoxals that form during glycolysis
in the cytoplasm. Glyoxalase I (Glo1) conjugates these dicarbon-
yls to GSH via a thioester bond, and Glo2 subsequently recog-
nizes the GSH moiety and cleaves this thioester. Mitochondria
contain Glo2, but not Glo1, suggesting that mitochondrial Glo2
has an alternate role (Rabbani et al., 2014). When human Glo2
(20 ng, 0.5 mU) was added to an incubation of S-acetylgluta-
thione and mitochondrial membranes, N-acetylation decreased
by 68% ± 9% (Figure 3C). Next, we tested whetherN-acetylation
by 2 mM AcCoA was also prevented by Glo2 (Figures 3C and
S3B). When GSH was combined with Glo2, N-acetylation
decreased by 54% ± 4% (n = 7, p < 0.0001). However, neither
GSH nor Glo2 alone significantly decreased N-acetylation by
AcCoA (Figures 3C and S3C).
Mitochondria contain mechanisms to recycle disulfides that
might also act on S-acetylglutathione or acetylated cysteine res-
idues. GSH reductase (GR) reduces glutathione disulfide (GSSG)
using NADPH, and the addition of yeast GR (2 ng, 0.44 mU),
1mMNAPDH, and 10mMGSHdid not decrease proteinN-acet-
ylation (Figure 3C). Glutaredoxin 2 (Grx2) reduces protein-GSH
mixed disulfides in the presence of GSH, and the addition of
human Grx2 (20 ng, 0.4 mU) with 10 mM GSH also failed to
decrease protein N-acetylation (Figure 3C). Protein disulfides
can be reduced by thioredoxin reductase (TR) and thioredoxin
(Trx), but the addition of TR (20 ng, 0.4 mU), Trx (5 mM), and
1 mM NADPH had no effect on protein acetylation (Figure S3D).
Mitochondria contain Sirt3, which can remove acetyl groups
from lysine residues. As expected, human recombinant Sirt3
(200 ng, 0.0004 mU) with 1 mM NAD+ reversed protein N-acety-
lation by AcCoA by 70% ± 4% (Figure 3C).
Next, we measured whether total protein acetylation by
14C-AcCoA was sensitive to GSH/Glo2 or NAD+/Sirt3 alone or
in combination. Incubation with 2 mM AcCoA for 6 hr led
to protein acetylation, and this was decreased 37% ± 2% ort3. Mitochondrial membranes were incubated with 2mMSuccCoA or AcCoA at
/mL), or Sirt3 (10 mg/mL) during the 6 hr incubation as indicated. (E) After SDS-
f lysine acetylation was quantified (n = 3 ± SD).
d. NS, not significant; *p < 0.05; **p < 0.01; ****p < 0.0001. See also Figure S3.
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Figure 4. Model of Thiol Involvement in Non-enzymatic Protein
Acetylation
(A) Coexistence of N-acetyllysine and S-acylcysteine. Overlap (orange) be-
tween lysine-containing peptides in the mouse liver S-acylome (yellow) (Gould
et al., 2015) and cysteine-containing peptides (red) in the mouse liver mito-
chondrial N-acetylome (blue) (Rardin et al., 2013).
(B) Model of non-enzymatic acetylation. The steady-state concentration of
reactive AcCoA is buffered lower by carnitine and carnitine acetyltransferase
(CrAT). The pKa and relative concentrations of GSH and protein thiols
(PrCysSH) determine the rate at which AcCoA reacts with their thiolate forms,
GS and PrCysS. NEM, IAM, and MMTS limit reversible thioester exchange
by blocking thiols. Glo2 shifts the equilibrium away from cysteine-bound acetyl
groups (PrCysSAc) by hydrolyzing S-acetylglutathione to acetate (Ac).
PrCysSAc not removed by GSH can irreversibly transfer to a nearby lysine
(PrLysNH2), where Sirt3 can degrade it. AcCoA is regenerated by AcCoA
synthetase (AceCS2), and this is regulated by N-acetylation and Sirt3.
See also Figure S4 and Table S1.37% ± 3% by the presence of GSH/Glo2 or NAD+/Sirt3, res-
pectively (Figure 3D). Glo2 and Sirt3 in combination decreased
acetylation by 53% ± 3%.
Glo2 Can Limit Acylation by Other AcCoA Species
Although AcCoA is the most common form of activated CoA
in vivo, it is not the only AcCoA present. CoA is used extensively
as a cofactor in metabolism, and many other moieties are conju-
gated to its thiol, e.g., succinylCoA in the tricarboxylic acid
cycle. One potential advantage of GSH/Glo2 over NAD+/
Sirt3 is that Glo2 is selective for GSH, but not the acyl moiety
conjugated to its thiol (Talesa et al., 1989; Vander Jagt, 1993).
To test whether Glo2 could diminish succinylation, we incubated2110 Cell Reports 18, 2105–2112, February 28, 2017mitochondrial membranes with 2 mM succinylCoA. GSH/Glo2,
but not NAD+/Sirt3, could decrease lysine succinylation (Figures
3E and 3F). Thus, GSH and Glo2 provide a broad specificity
mechanism for removing AcCoA-dependent modifications on
cysteine residues and consequently limiting their accumulation
on lysine residues.
DISCUSSION
Although reactions between AcCoA and cysteine thiols have
been noted previously (Bizzozero et al., 2001), almost all acety-
lation literature focuses on N-acetylation of lysine residues by
acetyltransferase enzymes (McDonnell et al., 2015). It has been
recognized that N-acetylation can also occur non-enzymatically
(Wagner and Payne, 2013; Wagner and Hirschey, 2014; Weinert
et al., 2015; Davies et al., 2016). Our results show that non-enzy-
maticN-acetylation frequently occurs indirectly via the reversible
S-acetylation of a nearby thiol. This thioester exchange, followed
by an intramolecular SN-transfer reaction to a proximal amine,
underlies the native chemical ligation of peptides (Thapa et al.,
2014), autoacetylation of tau protein (Cohen et al., 2013), and re-
actions in the active sites of enzymes such as acetyltransferases
(Yan et al., 2002; Cohen et al., 2013). Here we show that this in-
tramolecular SN-transfer reaction is likely to be widespread,
because it proceeds rapidly on a peptide lacking secondary
structure (Figures 2G and 2H). Although secondary structure is
not a requirement (Figure 2H) and the apparent KM of the reac-
tion is high (Figure 1C), we would expect enhancement of lysine
acetylation, in which the secondary structure stabilizes a nucle-
ophile or leads to AcCoA associating with a protein. AcCoA
shares an ADP-based backbone with ATP, NAD(P)H, and flavin
adenine dinucleotide (FADH), and Rossmann-fold binding sites
for these cofactors are prevalent throughout the cell.
Our use of HA to selectively cleave the thioester bond was
based on its widespread use to study S-acylation-dependent
membrane anchoring by S-acyltransferases and palmitoylCoA
(Roth et al., 2006). Consequently, some of the 627 S-acylcysteine
residues identified by MS in a mouse liver S-acylation dataset
could have been S-acetylated by AcCoA (Gould et al., 2015).
Merging this dataset with the 344 acetyllysines on peptides that
also contain a cysteine residue in amouse livermitochondrial ace-
tylome (Rardin et al., 2013) shows 66acetyllysinemodificationson
peptides,whichalsocontainedaS-acylatedcysteine residue (Fig-
ure 4A; Table S1). Thus, a number of acetylcysteine and acetylly-
sine residues coexist in vivo and may be worthy of further study.
Enrichment with anti-acetyllysine antibodies and improve-
ments in MS have identified an increasing number of lysine
acetylation sites (Rardin et al., 2013). However, purification of
acetylated from unacetylated peptides limits understanding of
stoichiometry and physiological importance (Weinert et al.,
2015). Bovine heart mitochondrial membranes contain 53 nmol
of exposed thiols per milligram of protein (Requejo et al.,
2010), and 0.78% of exposed cysteine thiols were acetylated
every hour by 2 mM AcCoA (see Supplemental Information).
This corresponds to 0.13% of exposed lysine residues N-acety-
lated each hour. Our in vitro concentration of exposed thiols is
265 mM, which is 100-fold lower than in vivo; consequently,
the rate of the reaction between AcCoA and protein could be
much higher. However, basal N-acetylation of the mitochondrial
membrane preparation, a function of acetylation and deacetyla-
tion, is 17%of that after 6 hr with 2mMAcCoA (Figure 2F). This is
equivalent to 0.13% of exposed lysine residues, a value consis-
tent with the median N-acetylation stoichiometry of liver mito-
chondrial proteins (0.11%) observed by MS (Weinert et al.,
2015). Thus, it is likely, at least in mitochondria, that most acety-
lome arises from low-level non-enzymatic acetylation.
The low stoichiometry of residue modification suggests this
process is analogous to oxidative stress, in which reactive
oxygen species (ROS) non-enzymatically modify protein, DNA,
and lipid. One striking difference is that AcCoA is central tometa-
bolism, so it cannot be directly degraded. This limits protective
strategies to preventing excess AcCoA and removal of acetyl
groups from proteins when they form. In addition to Sirt3, it
has been shown that carnitine acetyltransferase (CrAT) buffers
the AcCoA concentration by storing excess AcCoA as unreactive
O-acetylcarnitine (Figure S3B), thus limiting the thioester con-
centration and consequently cysteine and lysine acetylation
(Davies et al., 2016). Here we identify another system capable
of limiting CoA-derived modifications: the mitochondrial GSH
and Glo2 system (Figure 4B). Cytosolic Glo2 and Glo1 detoxify
glyoxals formed during glycolysis; however, an alternate function
is required for mitochondrial Glo2, because the matrix lacks
glycolysis andGlo1 (Rabbani et al., 2014).We suggest that ama-
jor function of matrix Glo2 is to degrade S-acetylglutathione and
thereby shift the equilibrium away from cysteine S-acetylation,
thus limiting acetylation of vital cysteine and lysine residues (Fig-
ure 4B). GSH at physiological concentrations is ineffective,
because the product of the reaction is S-acetylglutathione,
which could simply reacetylate protein, as thioester exchange
is faster than non-enzymatic hydrolysis (Bracher et al., 2011).
Glo2 is advantageous, because it increases the rate of hydrolysis
of a range of acylglutathione species (Talesa et al., 1989) without
affecting their corresponding AcCoAs.
Enzyme active sites have evolved over time to be efficient, and
many have intermediate steps with substrate covalently linked to
active site residues. We suspect protein modifications can result
from unintentional chemistry on less evolved protein surfaces,
where the second step releasing the modification is absent or
the target is a proximal amino acid. The AcCoA concentration
is 1,000-fold greater than most ROS and AcCoA cannot be
scavenged; together this represents both a problem for protein
function and an opportunity for regulation. Perhaps these regu-
latory pathways arose because the enzymes required to switch
them off, sirtuins, had already evolved to prevent non-specific
damage to protein.
Although many of the low-occupancy, potentially deleterious
acetylation sites identified by MSmay arise from the SN-transfer
described here, highly acetylated regulatory proteins may use a
combination of features to achieve a robust desirable signal.
Consequently, the relative contribution of proximal cysteine
thiols within signaling pathways would need to be explored
case by case with cysteine mutations. Furthermore, although
this work provides a potential explanation for the expression of
Glo2 in mitochondria, the physiological relevance of S-acylation
is still unknown and will need to be determined in vivo by the use
of knockout animals.EXPERIMENTAL PROCEDURES
Materials
Recombinant human Glo2 (25 nmol/min/mg) and Sirt3 (2 pmol/min/mg) were
from R&D Systems. Rabbit anti-acetyllysine (9441) was from Cell Signaling
Technology. Rabbit anti-succinyllysine (PTM-401) was from PTM Biolabs.
Bovine heart mitochondrial membrane fragments were prepared as described
previously and stored at 80C until used (Sharpley et al., 2006).
Radioactive Acetylation of Protein
Mitochondrial membrane fragments (5 mg/mL) were suspended in 20 mL of KPi
buffer (50 mM KH2PO4, 100 mM EDTA, 100 mM diethylenetriaminepentaacetic
acid (DTPA) [pH 7.8]) supplemented with NEM (25 mM), IAM (25 mM), MMTS
(25 mM), human Glo2 (1 mg/mL), human Sirt3 (10 mg/mL), NAD+ (1 mM) or
GSH (10 mM) as indicated. When NEM, IAM, and MMTS were used, they
were preincubated with mitochondrial membrane fragments for 15 min
at 37C before the addition of AcCoA. The reaction was started with 50 mM
14C-AcCoA and a 2 mMmixture of non-radioactive AcCoA and CoA before in-
cubation for up to 6 hr at either 0C or 37C. The reaction was quenched by
the addition of 980 mL of KPi buffer. To this 1 mL volume, a large excess of
DTT (20 mM), HA (50 mM), TCEP (20 mM), or GSH (20 mM) was sometimes
added, followed by a further 30 min incubation at 37C. Samples were spun
at 16,0003 g for 10 min with the supernatant discarded and the pellet washed
with a further 1mLof 50mMKPi buffer. The supernatantwasdiscarded, and the
inside of the tube dried. The pellet was resuspended in 50 mL of 20% (v/v) Triton
X-100.When14C-AcCoAwasaddedafter the incubation, 14Ccounts in thepellet
water space were 5% of the total at 6 hr. EDTA and DTPA were omitted from
thebuffer for experimentswithGlo2 (1 mg/mL) andSirt3 (10mg/mL). The specific
activity of recombinant Sirt3 is much lower than recombinant Glo2, hence the
addition of ten times as much protein.
Lysine Acetylation
Mitochondrialmembrane fragments (5mg/mL)were suspended in 20mLofNaPi
buffer (50 mM NaH2PO4, 100 mM EDTA, 100 mM DTPA [pH 7.8]) supplemented
with NEM (25 mM), IAM (25 mM), MMTS (25 mM), human Glo2 (1 mg/mL),
human Sirt3 (10 mg/mL), human Grx2 (1 mg/mL), yeast GR (0.1 mg/mL), E. coli
TR (1 mg/mL), E. coli Trx (5 mM), NAD+ (1 mM), NADPH (1 mM), or GSH
(10 mM) as indicated. The reaction was started with 2 mM AcCoA or 2 mM
S-acetylglutathione. When NEM, IAM, and MMTS were used, they were prein-
cubated for 15min at 37C before the addition of AcCoA orS-acetylglutathione
and then incubated for a further 3 or 6 hr at 37C. The samples were mixed 1:1
with loading buffer containing 200 mM DTT before being run on a 12% SDS-
PAGEgel. ThisDTT in the loadingbuffer reducesdisulfides suchas thosegener-
ated by MMTS and remove cysteine-bound acetyl groups. Because theMMTS
adduct is reduced by DTT in the loading buffer, the loss of signal does not result
from an altered antigen-antibody interaction.
Small-Molecule ESI MS
20 mL of fresh HCO3
 buffer (50 mM NH4HCO3 [pH 7.8]) were supplemented
with mitochondrial membrane fragments (5 mg/mL), AcCoA (2 mM), GSH
(10 mM), GSSG (5 mM), NEM (25 mM), IAM (25 mM), and MMTS (25 mM) as
indicated. They were then incubated for up to 6 hr at 37C before the addition
of 980 mL of HCO3
 buffer to quench the reaction. The samples were spun at
16,000 3 g for 2 min, and the filtered supernatant was directly infused into a
Xevo TQ-S triple quad mass spectrometer (Waters) at 50 mL/min. Samples
were assessed using ESI in negative mode.
MALDI of Synthetic Peptides
Two synthetic peptides were designed, butyryl-RYAKGCASR-NH2 (CysPep)
and butyryl-RYAKGSASR-NH2 (SerPep). The following features were de-
signed into the synthetic peptides: one tyrosine for quantification by UV,
one arginine at each end to facilitate MS of ion fragments, and a glycine be-
tween the lysine and the cysteine or serine for flexibility. The peptides also con-
tained a butyrated N-terminal amide and a C-terminal amide, a common
approach to improve stability and remove terminal charges that would not
be present on most peptides within an intact protein. Four additional deuter-
ated synthetic peptides were made as standards using deuterated butyricCell Reports 18, 2105–2112, February 28, 2017 2111
acid: d7-butyryl-RYAKGCASR-NH2 (d7-CysPep), d7-butyryl-RYAKGSASR-
NH2 (d7-SerPep), d7-butyryl-RYAKAcGCASR-NH2 (d7-AcCysPep), and d7-
butyryl-RYAKAcGSASR-NH2 (d7-AcSerPep). For the reaction, 200 mMcysteine
peptide, 200 mM serine peptide, 200 mM fresh AcCoA, and 1 mM fresh TCEP
were coincubated together in 25 mL of fresh 10 mM NH4HCO3 (pH 7.8) at
37C. After the incubation, a 10 mL aliquot of the reaction was added to
10 mL of either 40 mM DTT or H2O. The DTT sample was incubated for a
further 30 min at 37C. To both aliquots, 475 mL of 0.1% trifluoroacetic acid
(TFA) was added to quench further nucleophilic reactions, followed by 5 mL
of a deuterated standard mix (50 mM d7-CysPep, 50 mM d7-SerPep, 50 mM
d7-AcCysPep, and 50 mM d7-AcSerPep). For the 0 hr time point, AcCoA
was added after 0.1% TFA.
The sample was spotted on theMALDI plate using the bottom-layermethod.
In total, 20 spectra with ten shots each were collected per spot, using a min-
imum intensity of 1,000 and a maximum intensity of 10,000 as the selection
criteria. Peak intensities from three spots per experiment were quantified using
mMass, and the concentration was calculated using summed intensities of the
peptides and the d7 standards. Data are the average ± SEM of three experi-
ments on separate days, each with three spots.
Statistics and Data Processing
Statistical significance was determined, usually relative to incubation with
AcCoA, using a two-tailed Student’s t test or one-way ANOVA followed by a
Dunnett’s multiple comparison test in Prism v.6. The overlap of the S-acylation
(Gould et al., 2015) and N-acetylation (Rardin et al., 2013) datasets was deter-
mined using pgAdmin3. The peptides in the N-acetylation dataset contain two
neighboring tryptic peptides joined together, because trypsin does not cleave
at acetyllysine. Overlap occurred if either part of this miscleaved peptide was
also in the S-acylation dataset.
See Supplemental Information for further details.
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